STAT1, a well-established immune-related transcription factor, is frequently activated in endometrial carcinoma (59) and plays a critical role in upregulating MHC class I molecules and mediating interferon-induced antitumor responses (60)—both essential components of ICD signaling. This evidence concerns the gene STAT1 and endometrial carcinoma.